Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Stemness, Pluripotentiality, and Wnt Antagonism: sFRP4, a Wnt antagonist Mediates Pluripotency and Stemness in Glioblastoma

27 Dec 2018

Abstract excerpt

Background: Chemotherapeutic resistance of glioblastoma has been attributed to a self-renewing subpopulation, the glioma stem cells (GSCs), which is known to be maintained by the Wnt β−catenin pathway. Our previous findings demonstrated that exogeneous addition of the Wnt antagonist, secreted fizzled-related protein 4 (sFRP4) hampered stem cell properties in GSCs. Methods: To understand the molecular mechanism of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Neurogenesis and neuroplasticity mechanisms
Share to Wnt/β-catenin signaling in development and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30591679
DOI: 10.3390/cancers11010025

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Stemness, Pluripotentiality, and Wnt Antagonism: sFRP4, a Wnt antagonist Mediates Pluripotency and Stemness in GlioblastomaPMID 30591679Read ↗

Comparison of glioma stem cells to neural stem cells from the adult human brain identifies dysregulated Wnt- signaling and a fingerprint associated with clinical outcomeSemantic proximity Read ↗

Emerging targets for glioblastoma stem cell therapySemantic proximity Read ↗

Glioblastoma embryonic-like stem cells exhibit immune-evasive phenotypeSemantic proximity Read ↗

SOX transcription factors and glioma stem cells: Choosing between stemness and differentiationSemantic proximity Read ↗

Novel Perspectives on p53 Function in Neural Stem Cells and Brain TumorsSemantic proximity Read ↗

CHRDL1 Regulates Stemness in Glioma Stem-like CellsSemantic proximity Read ↗

Concise Review: NANOG in Cancer Stem Cells and Tumor Development: An Update and Outstanding QuestionsSemantic proximity Read ↗

SOX21 Suppresses Glioblastoma Growth by Repressing AP-1 ActivitySemantic proximity Read ↗

Activation of estrogen receptor beta signaling reduces stemness of glioma stem cellsSemantic proximity Read ↗

Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cellsSemantic proximity Read ↗

Sox2-dependent maintenance of mouse oligodendroglioma involves the Sox2-mediated downregulation of Cdkn2b, Ebf1, Zfp423 and Hey2Semantic proximity Read ↗

Cancer Stemness: p53 at the WheelSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.